October 25, 2014
   
Add to Google
Low-Dose Aspirin May Reduce Risk for Colon Cancer
email a friend print


Taking vitamin D supplements appears to help prevent falls in older adults, perhaps by strengthening bones. More >

Follow us on Twitter. Become a fan on Facebook. Receive updates via E-mail and SMS:







Would you like to ask our staff a question? >
Join the discussion and leave a comment on this article >


Low-Dose Aspirin May Reduce Risk for Colon Cancer

 

Aspirin in high doses has been shown to reduce the risk of colon cancer, but there are some risks associated with taking high doses of the drug over a long period of time. Now, a new study shows that low doses of aspirin may also cut colon cancer risk significantly, and may provide a safer method to protect against the disease — for those at high risk, at least.

Cancers in the upper part of the colon were reduced markedly (by up to 70% with aspirin treatment for over five years), but cancers of the lower colon did not seem to show this same reduction.

The new study analyzed data from four earlier studies that together included over 14,000 participants. The participants were given either aspirin or placebo to take for six years on average. Peter Rothwell and his colleagues at Oxford University followed up with the participants for an average of 20 years, keeping track of who developed colon cancer and how likely they were to survive it.

Compared to people in the control (placebo) group, participants who had taken aspirin over the years had a 24% reduced risk of developing colon cancer. Even more, those in the aspirin group who did develop it had a 35% reduced risk of dying from it, compared to participants in the placebo group. When the researchers looked at where in the colon the cancers developed, they found that cancers in the upper part of the colon were reduced markedly (by up to 70% with aspirin treatment for over five years), but cancers of the lower colon did not seem to show this same reduction.

Aspirin’s benefits were seen at doses of 75 mg per day, and the researchers did not find that doses higher than this offered any additional benefit.

In an accompanying editorial in the October 21, 2010 issue of The Lancet, Robert Benamouzig and Bernard Uzzan write that the new study may spur clinicians to recommend aspirin to their patients who are at high risk (perhaps because of family history). People who are at not considered high-risk should not necessarily start taking aspirin in hopes of warding off the disease. More research will be needed to determine what dosing is the safest and most effective, as well as how aspirin actually works to protect the colon against the disease.

November 3, 2010






 


 
Add Comment
NOTE: We regret that we cannot answer personal medical questions.

Name


Comment

Characters remaining:



Readers Comments
No comments have been made











This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.





The Doctor Will See You Now   |   LEGAL RESTRICTIONS AND TERMS OF USE OF THIS SITE. USE OF THIS SITE IS YOUR AGREEMENT TO THESE TERMS.
Copyright 2014 interMDnet Corporation. All rights reserved.
About Us | Privacy Policy | Disclaimer | System Requirements